Changes to an Approved Application: Biological Products: Human Blood and Blood Components Intended for Transfusion or for Further Manufacture: Final Guidance
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 1, 2014
August 22, 2019
d3ff905e-6a8a-440f-bdde-3f125c0e2af2
Related Documents
Considerations for the Development of Dried Plasma Products Intended for Transfusion: Guidance for Industry
Guidance DocumentDecember 19, 2019Center for Biologics Evaluation and Research
Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products: Guidance for Industry
Guidance DocumentJune 27, 2015Center for Biologics Evaluation and Research
Recommendations for Microbial Vectors Used for Gene Therapy: Guidance for Industry
Guidance DocumentSeptember 16, 2016Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.